A detailed history of Commonwealth Equity Services, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 10,357 shares of OCUL stock, worth $117,759. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,357
Previous 14,360 27.88%
Holding current value
$117,759
Previous $133,000 9.02%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

SELL
$9.09 - $13.6 $36,387 - $54,440
-4,003 Reduced 27.88%
10,357 $121,000
Q2 2025

Aug 06, 2025

BUY
$6.02 - $9.46 $86,447 - $135,845
14,360 New
14,360 $133,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $875M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.